Suppr超能文献

肝移植治疗慢加急性肝衰竭。

Liver transplantation for acute-on-chronic liver failure.

机构信息

Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China.

出版信息

Hepatol Int. 2009 Dec;3(4):571-81. doi: 10.1007/s12072-009-9148-8. Epub 2009 Aug 13.

Abstract

PURPOSE

To evaluate the outcome of liver transplantation for acute-on-chronic liver failure.

PATIENTS AND METHODS

From November 1991 to December 2007, 517 patients underwent liver transplantation at Queen Mary Hospital, Hong Kong. Among them, 149 had acute-on-chronic liver failure as defined in the recent Asian Pacific Association for the Study of Liver Consensus Meeting. Their clinical data were reviewed and their survival outcomes were compared with those of patients who underwent liver transplantation for fulminant hepatic failure and for cirrhosis only in the same period.

RESULTS

The patients with acute-on-chronic liver failure included 50 patients having acute exacerbation of chronic hepatitis B and 99 cirrhotic patients with acute deterioration. Their median model for end-stage liver disease scores were 35 and 37, respectively. Preoperative infection (35%), hepatorenal syndrome (38%), and respiratory failure (28.8%) were common. One hundred and three patients received living donor liver grafts and 46 patients received deceased donor liver grafts. The hospital mortality rate was 4.7%. The 5-year survival rates were 93.2% for patients with acute exacerbation of chronic hepatitis B and 90.5% for cirrhotic patients with acute deterioration. The results were similar to those of the patients with fulminant hepatic failure (n = 37) and the patients having cirrhosis only (n = 301).

CONCLUSIONS

Liver transplantation for acute-on-chronic liver failure is life-saving, and the survival rates it attains are similar to those attained by transplantation for other liver conditions.

摘要

目的

评估慢性加急性肝衰竭肝移植的疗效。

患者与方法

1991 年 11 月至 2007 年 12 月,香港玛丽医院共进行了 517 例肝移植手术,其中 149 例符合近期亚太肝脏研究学会共识会议中关于慢性加急性肝衰竭的定义。我们对这些患者的临床资料进行了回顾,并将其生存结局与同期因暴发性肝衰竭和单纯肝硬化而行肝移植患者的结局进行了比较。

结果

慢性加急性肝衰竭患者中,50 例为慢性乙型肝炎急性加重,99 例为肝硬化急性恶化。他们的终末期肝病模型评分中位数分别为 35 和 37。术前感染(35%)、肝肾综合征(38%)和呼吸衰竭(28.8%)较为常见。103 例接受活体供肝移植,46 例接受尸体供肝移植。住院死亡率为 4.7%。慢性乙型肝炎急性加重患者的 5 年生存率为 93.2%,肝硬化急性恶化患者的 5 年生存率为 90.5%。这两组患者的结果与暴发性肝衰竭患者(n=37)和单纯肝硬化患者(n=301)的结果相似。

结论

慢性加急性肝衰竭肝移植可挽救生命,其生存率与其他肝脏疾病肝移植的生存率相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验